Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boceprevir + PEG/RBV in Genotype 4 Chronic Hepatitis C
NCT01653236Phase 3Unknown
- Sponsor
- Theodor Bilharz Research Institute
- Start
- Dec 2013
- Primary completion
- Dec 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of boceprevir in hepatitis C (HCV), sponsored by Theodor Bilharz Research Institute. Status: unknown.
02
Drugs
boceprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01653236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01653236.